Medical Research and Surveillance Services

This Request for Information (RFI)/Sources Sought (SS) Notice is for market research, information, and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the Walter Reed Army Institute of Research (WRAIR) or the US Army Medical Research Acquisition Activity (USAMRAA). The purpose of this requirement is to provide non-personal service(s) services and expertise to conduct medical research and surveillance for AFRIMS’ projects within the country of Laos.

This support shall include field advertisement, the site rental space for subject enrollment, subject compensation, sample collection, sample processing, point-of-care, and preliminary lab testing, moderate to complex lab testing, pathogen identification, sample storage, and transporting of the samples to AFRIMS or another lab to conduct more advanced laboratory testing.

Surveillance and research shall be on malaria prevalence and antimalarial drug resistance, bacteria with antimicrobial resistance, sexually transmitted pathogens, respiratory viral pathogens, bacterial pathogens, agents of parasitic disease and other emerging infections found in the LPAF ranks and in the Laos citizens.

Products that may be evaluated in clinical trials include anti-malarial drugs and/or vaccines, anti-viral drugs, anti-microbial drugs, other potential candidates with activity against infectious disease agents as well as diagnostic tests. The contractor shall provide office space, utilities, as well as security per local regulations. This announcement is not a formal solicitation and is not a request for proposal. No contract will be awarded from this announcement.

No reimbursement will be made of any costs to provide information in response to this announcement or any follow up information requests. Availability of any formal solicitation will be announced under a separate announcement. This synopsis is for market research, information, and planning purposes only and is not to be construed as a commitment by the Government. Each response must reference the sources sought title. All proprietary information should be marked as such. Responses will be held confidential if requested. Please submit fact sheets/capability Statements may be emailed to:

john.l.fitzsimmons8.civ@health.mil. Responses must be received no later than 15 August 2024.